Atea Pharmaceuticals 10K 2023 Annual report | AVIR Filing

Content analysis

Positive
Negative
Uncertain
Constraining
Legalese
Litigous
Readability	H.S. junior Avg

New words: activist, agenda, appellate, awaiting, BAL, cardiac, CFO, cheaper, CI, coordinating, criterion, CSF, denote, depository, download, DPF, dynamic, electrocardiogram, ensitrelvir, enstirelvir, eradication, Erroneously, Eurasia, extraordinary, FDIC, fit, formula, fundamental, fundraising, futile, futility, gave, hoc, immaterial, Invivyd, landlord, Likewise, macroeconomic, nasopharyngeal, NextGen, NIST, Nsp, obeldesivir, officially, PCR, Pharmacy, premarket, PTAB, purportedly, Qatar, receptive, reoccurrence, repolarization, resilient, resorting, Retail, runway, Schema, seeded, shareholder, Silicon, speculative, sponsorship, Sr, subscription, sunsetting, surpassed, surveyed, thrive, underway, uninterrupted, Unitary, unrestricted, UPC, uphold, Valley, vast, velpatasivir, VP, weekly, Xocova, yearly

Removed: absence, AG, Aid, allocating, Alnylam, altogether, analyze, analyzing, anemia, antibody, Asia, assembled, AstraZeneca, attachment, authored, backup, belonging, beneficially, bilayer, bind, Biogen, Biopharma, breath, bundled, call, capsid, catalyze, Chiron, circulate, clarity, Codification, cofounded, cold, collateralize, combat, comprise, conservation, constraint, coronaviridae, cough, dddp, ddrp, deteriorate, directed, dollar, dsRNA, East, elderly, Enanta, encased, envelope, enveloped, Epivir, euro, executed, exemption, exert, expedient, fatigue, feel, forecast, fourth, furnishing, genotype, GlaxoSmithKline, glycoprotein, Golgi, heightening, hemolytic, Hoffmann, hybrid, immigration, indefinite, inferred, intention, judgement, kidney, La, makeup, marketability, measuring, messenger, metabolic, Middle, mimic, minimize, mistakenly, month, movement, muscle, nascent, neutralizing, nonstructural, nucleic, nucleocapsid, obesity, OPM, opportunistically, overcome, overwork, partly, pattern, paused, permeation, pound, practical, precautionary, predominant, prevalent, prioritization, prioritized, promised, proportional, protective, provincial, PWERM, quantitation, redeemable, region, reinvestment, Relenza, representing, reversal, Reyataz, RSV, sequelae, serine, shell, Shield, Shire, soliciting, Southeast, spherical, spread, sterling, strain, structurally, subsided, Summer, surface, Sustiva, syncytial, syndrome, synthetic, TCA, template, teratogenicity, termed, threatening, throat, tract, transcribe, transcribed, transferred, transferring, transitional, translated, transmembrane, transport, turnover, Tyzeka, unapproved, unbilled, Valeant, Valtrex, Videx, virally, virion, Weakening, Wellferon, wholesale, worked, Xofluza, Zerit, Zika

Atea Pharmaceuticals (AVIR) 10-K2023 FY Annual report

Content analysis